Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory, with Excess of Blasts

Explore clinical trials studying Anemia, Refractory, with Excess of Blasts. Study availability and eligibility vary by location and protocol.

244 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory, with Excess of Blasts trial results

Completed

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

NCT00454480

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +18 more
Locations
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
  • Royal United Hospital Bath, England, United Kingdom
  • Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, England, United Kingdom
View all 96 locations
View Trial Details
Completed

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

NCT00004255

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations
  • University of California San Diego Cancer Center La Jolla, California, United States
  • Presbyterian-St Luke's Medical Center Denver, Colorado, United States
  • Lombardi Cancer Center Washington D.C., District of Columbia, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
View all 15 locations
View Trial Details

Related conditions